Updated MOU strengthens SG-Malaysia pharmaceutical ties

The agreement was originally signed in 2012.

The Health Sciences Authority (HSA) and Malaysia's Ministry of Health renewed their Memorandum of Understanding (MOU) on pharmaceutical products and cosmetics cooperation on 6 May.

This agreement, originally signed in 2012, strengthens collaboration in post-market vigilance, enforcement, and clinical trial standards.

ALSO READ: King of Malaysia to visit SG on state tour from May 6-7

Both regulatory bodies, HSA and Malaysia's National Pharmaceutical Regulatory Agency (NPRA), ensure the safety and efficacy of pharmaceuticals and cosmetics within their nations.

Dr. Choong May Ling, CEO of HSA, and Ms. Norhaliza A. Halim, Senior Director of Pharmaceutical Services at Malaysia's Ministry of Health, signed the MOU at HSA's Outram building in Singapore.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia